Overview

Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension

Status:
Recruiting

Trial end date:
2021-10-31

Target enrollment:

Participant gender:

Summary

A Randomized, Double-blind, Multicenter, Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypertension

Phase:

Phase 2

Details

Lead Sponsor:

Handok Inc.

Treatments:

Amlodipine
Irbesartan